February #44 : The Party’s Still On - by Lark Lands, PhD

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

They Shoot Barebackers, Don't They?

A Ride on the Wild Side

Secrets & Lies

Brain Drain

All in the Family

Is Stoning Next?

Tee'd Off

Say What

Heart to HAART

S.O.S.

To the Editor

POZarazzi: Stardust Memories

Tee'd Off

Say What

The Stiles Files

You've Got Mail!

Ad of the Month: Oh, Good Lords!

Cry Cannabis

An Affair to Remember

Techno Truth

POZ Planet: Vital Stats

Behind the Eight Ball

Voter Fraud

Show & Tell

POZ Picks

Northern Disclosure

The Wizard of Roz

Obits

Heart to HAART

Ever Laughter

A River Ran Through Him

One Toke Over the Line

Talk Therapy

New Drug Watch

The Party’s Still On

The “No Nukes” Movement

Vits Help the Rits Go Down

Female Trouble

Not My Type

Where to Find It

Big Daddy

Aunt Evelyn's Letters

Verse: Eulogy for Brad



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

February 1999

The Party’s Still On

by Lark Lands, PhD

Call it a parallel universe: While here at POZ we’re busy barking about all the problems of the protease era, the buzz among certain treatment activists is that the “c” word may soon be on the lips of scientists. Our best guess is that the word heard is likely to be control, not cure. Even so, the body’s own long-term control of HIV would still be cause to celebrate.

But for now, Anthony Fauci, MD, Clifford Lane, MD, and their fellow NIHers whose research has tongues wagging are making no big noise, just announcing another small step on the road to remission. In round 1 of NIH vs. HIV (see "Draining the Reservoirs,” POZ, November 1998), Fauci reported that in three of 14 PWAs on a combination of HAART and interleukin-2 (IL-2, an immune-system regulatory protein), there was no detectable virus in resting CD4 cells in the bloodstream, a main “safe haven” where HIV hides from aggressive antiretroviral therapy. Now, in round 2, examination of lymph-node tissue from one of the three has also found no virus. “Our new data suggest that in HAART-treated patients, interleukin-2 may have a role in reducing this ‘reservoir’ of virus, where HIV would otherwise remain sequestered from the immune system,” says Fauci.

The researchers suspect that other hidden viral reservoirs exist, including in the brain, testes, CD4 cells in gut lymph tissue, and such other immune cells as macrophages. But the hope is that diminishing the HIV stored in these vaults might enable the immune system to control the virus, especially if supported by periodic HAART and/or IL-2 or other immune boosters. Fauci says, “The final proof of the pudding will be discontinuation of HAART and long-term follow-up.” Both his group and Harvard researchers led by Bruce Walker, MD, are now embarking on round 3: stopping therapy to test this possibility.




[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    acousticmat
    Tucson
    Arizona


    RyGuy00
    New York
    New York


    latinpozdallas
    Dallas
    Texas


    donnyp
    liberty
    Kentucky
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.